I joined NDORMS in 2017 as a member of the Musculoskeletal Pharmacoepidemiology group in order to enter a DPhil programme at the beginning of the academic year 2017/2018. My research is going to be focused on method development for the risk-benefit evaluation of surgical procedures.
Previously I worked at the Department of Clinical Epidemiology of the Aarhus University, collaborated with the Department of Medical Informatics of the Erasmus Medical Center and studied medicine and mathematics in Budapest.
Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study.
Hawley S. et al, (2019), Clin epidemiol, 11, 197 - 205
Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU-ADR Alliance
Berencsi K. et al, (2018), Pharmacoepidemiology and drug safety, 27, 189 - 189
Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance
Ali MS. et al, (2018), Pharmacoepidemiology and drug safety, 27, 186 - 187
Estimating incidence of adverse events following vaccination in observational databases when exposure information is unavailable: A contribution from the advance project
Dodd C. et al, (2018), Pharmacoepidemiology and drug safety, 27, 493 - 494
Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool.
Stidsen JV. et al, (2018), Diabetes metab res rev, 34